Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)

This Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, Franc...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2019
Language:English
Physical Description:1 electronic resource (230 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993548231804498
ctrlnum (CKB)4100000010106116
(oapen)https://directory.doabooks.org/handle/20.500.12854/61058
(EXLCZ)994100000010106116
collection bib_alma
record_format marc
spelling Hofman, Paul auth
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
Towards New Promising Discoveries for Lung Cancer Patients
MDPI - Multidisciplinary Digital Publishing Institute 2019
1 electronic resource (230 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
This Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, France) (Nice, September 2018). The central theme of JMLC is to discuss new advances and exchange ideas regarding lung cancer. Notably, the talks covered different topics on new therapeutic strategies (targeted therapy and immuno-oncology), molecular and cellular biology, biomarkers, and the epidemiology of lung cancer. Special attention was also given to lung cancer in elderly patients. The articles published in this Special Issue covered subjects such as the assessment of new biomarkers and new approaches for the early detection of lung cancer, epidemiological data, and emphasized a place for the newly characterized cellular pathways in lung cancer, which opens room for therapeutic perspectives for lung cancer patients.
English
microRNAs
multiplexed
screening
education
non-smoker
image analysis
artificial intelligence
research
lung cancer
spatial analysis
optimization
fluorescence
geriatric assessment
geriatric interventions
TNBC
liquid biopsy
non-small cell lung cancer
integrated approaches
well-being
hormone-like action
EGFR mutations
reversal of EMT
tumor plasticity
immune profiling
macrophage
multiplexed methodologies
targeted treatment
techniques
immune-oncology
bioinformatics
MALAT1
long non-coding RNAs
CD8 T Cells
personal medicine
EGFR TKIs
lncRNA
hormones
elderly
interleukin-1? and immunometabolism
chromogenic
xenograft
metastasis
PD-1/PD-L1 checkpoint blockade
immunotherapy
molecular
cancer tissues
digital
NSCLC
immune blockade
lung adenocarcinoma
circulating tumor cells
brightfield
non-coding RNAs
older adults
cancer
tumor microenvironment
aging
rational therapy
3-03921-451-9
Calin, George auth
Mani, Sendurai auth
language English
format eBook
author Hofman, Paul
spellingShingle Hofman, Paul
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
author_facet Hofman, Paul
Calin, George
Mani, Sendurai
author_variant p h ph
author2 Calin, George
Mani, Sendurai
author2_variant g c gc
s m sm
author_sort Hofman, Paul
title Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
title_full Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
title_fullStr Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
title_full_unstemmed Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
title_auth Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
title_alt Towards New Promising Discoveries for Lung Cancer Patients
title_new Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
title_sort towards new promising discoveries for lung cancer patients: a selection of papers from the first joint meeting on lung cancer of the fhu oncoage (nice, france) and the md anderson cancer center (houston, tx, usa)
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2019
physical 1 electronic resource (230 p.)
isbn 3-03921-452-7
3-03921-451-9
illustrated Not Illustrated
work_keys_str_mv AT hofmanpaul towardsnewpromisingdiscoveriesforlungcancerpatientsaselectionofpapersfromthefirstjointmeetingonlungcancerofthefhuoncoagenicefranceandthemdandersoncancercenterhoustontxusa
AT calingeorge towardsnewpromisingdiscoveriesforlungcancerpatientsaselectionofpapersfromthefirstjointmeetingonlungcancerofthefhuoncoagenicefranceandthemdandersoncancercenterhoustontxusa
AT manisendurai towardsnewpromisingdiscoveriesforlungcancerpatientsaselectionofpapersfromthefirstjointmeetingonlungcancerofthefhuoncoagenicefranceandthemdandersoncancercenterhoustontxusa
AT hofmanpaul towardsnewpromisingdiscoveriesforlungcancerpatients
AT calingeorge towardsnewpromisingdiscoveriesforlungcancerpatients
AT manisendurai towardsnewpromisingdiscoveriesforlungcancerpatients
status_str n
ids_txt_mv (CKB)4100000010106116
(oapen)https://directory.doabooks.org/handle/20.500.12854/61058
(EXLCZ)994100000010106116
carrierType_str_mv cr
is_hierarchy_title Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1792756686652440577
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03940nam-a2200997z--4500</leader><controlfield tag="001">993548231804498</controlfield><controlfield tag="005">20231214132826.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03921-452-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010106116</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/61058</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010106116</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hofman, Paul</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Towards New Promising Discoveries for Lung Cancer Patients</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (230 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, France) (Nice, September 2018). The central theme of JMLC is to discuss new advances and exchange ideas regarding lung cancer. Notably, the talks covered different topics on new therapeutic strategies (targeted therapy and immuno-oncology), molecular and cellular biology, biomarkers, and the epidemiology of lung cancer. Special attention was also given to lung cancer in elderly patients. The articles published in this Special Issue covered subjects such as the assessment of new biomarkers and new approaches for the early detection of lung cancer, epidemiological data, and emphasized a place for the newly characterized cellular pathways in lung cancer, which opens room for therapeutic perspectives for lung cancer patients.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiplexed</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">education</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-smoker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">image analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">artificial intelligence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">research</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spatial analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">optimization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluorescence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">geriatric assessment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">geriatric interventions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TNBC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid biopsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-small cell lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">integrated approaches</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">well-being</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hormone-like action</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGFR mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reversal of EMT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor plasticity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune profiling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">macrophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiplexed methodologies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">techniques</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune-oncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioinformatics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MALAT1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long non-coding RNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CD8 T Cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personal medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGFR TKIs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lncRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hormones</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">elderly</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interleukin-1? and immunometabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chromogenic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">xenograft</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-1/PD-L1 checkpoint blockade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer tissues</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">digital</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NSCLC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune blockade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung adenocarcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circulating tumor cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brightfield</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-coding RNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">older adults</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rational therapy</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03921-451-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calin, George</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mani, Sendurai</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-06 05:13:33 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-02-01 22:26:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338822090004498&amp;Force_direct=true</subfield><subfield code="Z">5338822090004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338822090004498</subfield></datafield></record></collection>